Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double‐blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Movement Disorders

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.23473PMID 21259343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Botulinum toxin type B vs. type A in toxin‐naïve patients with cervical dystonia: Randomized, double‐blind, noninferiority trial

  2008cited by this paper
• Successful Treatment of Drooling in Children with Neurological Disorders with Botulinum Toxin A or B

  2008cited by this paper
• Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis

  2008cited by this paper
• NeuroBloc/Myobloc: unique features and findings.

  2008influential reference
• Evidence for the effectiveness of botulinum toxin for sialorrhoea

  2008cited by this paper
• Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.

  2007cited by this paper
• A Double-blind, Randomized, Crossover Study of Prosigne Versus Botox in Patients With Blepharospasm and Hemifacial Spasm

  2007cited by this paper
• Using translational medicine to understand clinical differences between botulinum toxin formulations

  2006cited by this paper
• Drooling of saliva: a review of the etiology and management options.

  2006cited by this paper
• Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study

  2006cited by this paper
• Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study

  2005cited by this paper
• Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

  2005cited by this paper
• Autonomic function after botulinum toxin type A or B: A double-blind, randomized trial

  2005cited by this paper
• Botulinum Toxin A and B: A Comparative Dosing Study for Spasmodic Dysphonia

  2005cited by this paper
• Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis

  2005cited by this paper
• Aplicação de toxina botulínica tipo A para reduzir a saliva em pacientes com esclerose lateral amiotrófica

  2005cited by this paper
• Autonomic side effects of botulinum toxin type B therapy.

  2004cited by this paper
• Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm.

  2004cited by this paper
• A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease

  2004cited by this paper
• Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease.

  2004cited by this paper
• Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study

  2004cited by this paper
• Botulinum toxin B reduces sialorrhea in parkinsonism

  2003cited by this paper
• Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.

  2003cited by this paper
• Botulinum Toxin Type B (MYOBLOC) Versus Botulinum Toxin Type A (BOTOX) Frontalis Study: Rate of Onset and Radius of Diffusion

  2003cited by this paper
• Botulism type B presenting as pure autonomic dysfunction

  2003cited by this paper
• A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.

  2003cited by this paper
• Botulinum toxin type B in blepharospasm and hemifacial spasm.

  2003cited by this paper
• Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion

  2003cited by this paper
• Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

  2003cited by this paper
• A randomized trial of botulinum toxin A for treatment of drooling

  2003cited by this paper
• Comparison of Botulinum Toxin Types A And B: A Bilateral and Double‐Blind Randomized Evaluation in the Treatment of Canthal Rhytides

  2003cited by this paper
• Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia

  2002cited by this paper
• Autonomic Side Effects of Botulinum Toxin Type B Treatment of Cervical Dystonia and Hyperhidrosis

  2002cited by this paper
• Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia

  2002cited by this paper
• Botulinum Toxin to Reduce Saliva Flow: Selected Indications for Ultrasound‐Guided Toxin Application Into Salivary Glands

  2002cited by this paper
• Clinical Study of Botulinum‐A Toxin in the Treatment of Sialorrhea in Children With Cerebral Palsy

  2002cited by this paper
• Botulinum toxin type B for treatment of axillar hyperhidrosis

  2002cited by this paper
• Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders

  2001cited by this paper
• Botulinum toxin A as treatment for drooling saliva in PD

  2000cited by this paper
• Valproate-induced hyperammonemic encephalopathy in the presence of topiramate

  2000cited by this paper
• Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

  2000cited by this paper
• Botulinum toxin is a useful treatment in excessive drooling in saliva.

  1999cited by this paper
• Magnetic resonance imaging and vertebral artery dissection

  1999cited by this paper
• Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

  1999cited by this paper
• EFFECT OF ANTIREFLUX MEDICATION ON SALIVARY DROOLING IN CHILDREN WITH CEREBRAL PALSY

  1996cited by this paper
• Botulinum toxin treatment of essential head tremor

  1995cited by this paper
• Rasch analysis of Visual Analog Scale measurements before and after treatment of Patellofemoral Pain Syndrome in women.

  1995cited by this paper

• Botulinum Toxin Injections for Drooling Improve Dysphagia in Patients with Parkinson's Disease.

  2026cites this paper
• High-Dose Rimabotulinumtoxin B for Chronic Sialorrhea: A Case Report on the Safety and Efficacy of 20,000 Units Injection.

  2025cites this paper
• [Evaluation of the efficacy and safety of botulinum toxin type A injections for the prevention of aspiration complications in patients with neurogenic dysphagia and posterior sialorrhea of various etiologies].

  2025cites this paper
• Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis

  2025cites this paper
• Zebrafish in Neurotoxin Research: Insights into Botulinum Toxicity, Mechanisms, and Therapy.

  2025cites this paper
• Management of Gastrointestinal Symptoms in Parkinson’s Disease

  2025cites this paper
• From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction

  2024cites this paper
• Einsatzmöglichkeiten des Botulinum- Neurotoxins bei der Parkinson-Krankheit

  2024cites this paper
• Botulinum Toxin for the Management of Parkinson’s Disease: A Systematic Review

  2024cites this paper
• Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson’s disease: a systematic review and network meta-analysis

  2023influential citation
• Iranian clinical practice guideline for amyotrophic lateral sclerosis

  2023cites this paper
• Palliative care principles in ALS.

  2023cites this paper
• BoNT clinical trial update: Sialorrhea.

  2023cites this paper
• Alteration of myoepithelial cells during botulinum toxin type A-inhibited salivary secretion.

  2023cites this paper
• Explore the pharmacological basis of ShengJiYiSui decoction in the treatment of amyotrophic lateral sclerosis based on network pharmacology and molecular docking technology.

  2023cites this paper
• Botulinum toxin treatment in parkinsonism.

  2023cites this paper
• Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review

  2023cites this paper
• Botulinum Toxin for Drooling in Adults with Diseases of the Central Nervous System: A Meta-Analysis

  2023cites this paper
• Botulinum toxin in the management of parkinsonian disorders.

  2023cites this paper
• Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience

  2022cites this paper
• Using Intensity Modulated Radiation Therapy for the Treatment of Sialorrhea in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.

  2022cites this paper
• Therapie der Sialorrhoe mit Botulinumtoxin – ein Update

  2022cites this paper
• Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update

  2022cites this paper
• Drooling in Parkinson's disease and current treatment options

  2022cites this paper
• Amyotrophic lateral sclerosis

  2022cites this paper
• Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal

  2021cites this paper
• Botulinum Toxin in Movement Disorders: An Update

  2021cites this paper
• An Update on Botulinum Toxin in Neurology.

  2021cites this paper
• Botulinum Neurotoxins as a Therapeutic

  2021cites this paper
• Efficacy and safety of botulinum toxin for treating sialorrhea: A systematic review and meta‐analysis

  2021cites this paper
• Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Drooling and dysphagia in Parkinson's disease

  2021cites this paper
• Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis

  2021cites this paper
• Nonaesthetic Applications for Botulinum Toxin in Plastic Surgery

  2020cites this paper
• Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions

  2020cites this paper
• Microsoft Word-Versão Final Tese Luisa Correa.docx

  2020cites this paper
• Clinical duration of action of different botulinum toxin types in humans.

  2020cites this paper
• Neurologic and Neurodegenerative Diseases of the Larynx

  2020cites this paper
• Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults

  2020cites this paper
• Saliva Management

  2020cites this paper
• Qualität der Therapie von Speicheldrüsenerkrankungen

  2020cites this paper
• Injections de toxine botulique en pathologie salivaire

  2020cites this paper
• Management of Primary Lateral Sclerosis

  2020cites this paper
• Therapy of Sialorrhea with Botulinum Neurotoxin

  2019cites this paper
• Hypersalivation – Aktualisierung der S2k-Leitlinie (AWMF) in gekürzter Darstellung

  2019cites this paper
• Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

  2019cites this paper
• Beatmung bei neuromuskulären Erkrankungen

  2019cites this paper
• Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson’s Disease: A Systematic Review

  2019influential citation
• The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)

  2019cites this paper
• SIAXI

  2019cites this paper
• Hypersalivation: update of the German S2k guideline (AWMF) in short form

  2019cites this paper
• Treatment of Drooling in Parkinson’s Disease

  2019cites this paper
• Theme 7 Pre-clinical therapeutic strategies

  2019cites this paper
• IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study

  2019cites this paper
• [Therapy of sialorrhea with botulinum toxin].

  2019cites this paper
• Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience

  2018cites this paper
• Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.

  2018cites this paper
• Botulinum toxin in movement disorders

  2018cites this paper
• Therapeutic uses and efficacy of botulinum toxin in orofacial medicine

  2018cites this paper
• Gastrointestinal Dysfunction in Parkinson’s Disease

  2018cites this paper
• Theme 7 Pre-clinical therapeutic strategies

  2018cites this paper
• Mitos y evidencias en el empleo de la toxina botulínica: neurofarmacología y distonías

  2018cites this paper
• Motor Neuron Disease

  2018cites this paper
• Neues zur Amyotrophen Lateralsklerose

  2017cites this paper
• Botulinum Toxin Therapy for Parkinson's Disease

  2017cites this paper
• Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis

  2017cites this paper
• Nonmotor Symptoms in Amyotrophic Lateral Sclerosis: A Systematic Review.

  2017influential citation
• [Salivation after stroke].

  2017cites this paper
• RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

  2017cites this paper
• Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis

  2017cites this paper
• Efficacy of Incobotulinumtoxin Type A (Xeomin ® ) in the Management of Sialorrhea in Neurodegenerative Diseases

  2017cites this paper
• Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis

  2017cites this paper
• Botulinum toxin for drooling in Parkinson’s disease

  2016cites this paper
• 5.01.512 Botulinum Toxin

  2016cites this paper
• Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism

  2016influential citation
• Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea.

  2016cites this paper
• Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.

  2016cites this paper
• Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea

  2016cites this paper
• Toxina botulínica tipo A en el tratamiento de sialorrea en pacientes con enfermedad de Parkinson

  2015cites this paper
• The Cu,Zn-superoxide dismutase (SOD1) exerts neuroprotective effects in Amyotrophic Lateral Sclerosis through the Ca2+/ERK1/2/Akt prosurvival pathway

  2015cites this paper
• Botulinum Toxin Treatment for Sialorrhea

  2015cites this paper
• Repeated treatments of drooling with botulinum toxin B in neurology

  2015cites this paper
• AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION

  2015cites this paper
• A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases

  2015cites this paper
• The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders

  2015influential citation
• Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia

  2015cites this paper
• Clinical comparison of botulinum toxin in motor and autonomic disorders: Similarities and differences.

  2015cites this paper
• [Hypersalivation in Parkinson's disease: causes and treatment options].

  2015cites this paper
• Clinical differences between botulinum neurotoxin type A and B.

  2015cites this paper
• Sialorrhoea: How to Manage a Frequent Complication of Motor Neuron Disease

  2015cites this paper
• Botulinum Toxin Treatment for Sialorrhea

  2015cites this paper
• The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson’s disease

  2015cites this paper
• Developing an outcome measure for excessive saliva management in MND and an evaluation of saliva burden in Sheffield

  2015cites this paper
• Parkinson’s Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options – A Practise Guide

  2015cites this paper
• Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.

  2015cites this paper
• A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis

  2015cites this paper
• Botulinum neurotoxins as therapeutics

  2014cites this paper
• Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.

  2014cites this paper
• Sialorrhea in Patients with Parkinson's Disease: Safety and Administration of Botulinum Neurotoxin

  2014cites this paper